FROM NURSE, TO ROLES IN MEDTECH MARKETING, CHAMPIONING WOMEN’S HEALTH
With
Aggie Cox
Government Affairs & Marketing Director – ANZ, Hologic
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | July 2026
Aggie Cox is a senior healthcare marketing leader and women’s health advocate with over two decades of experience spanning clinical care, medical technology, and executive marketing leadership. She currently serves as Government Affairs & Marketing Director for Australia and New Zealand at Hologic, Inc., a global medical technology company dedicated to advancing women’s health through early detection, diagnosis, and treatment.
With an early career as a Registered Nurse, including frontline experience in emergency and trauma care, Aggie brings a rare clinical lens to health leadership—grounding strategy, communication, and advocacy in real patient needs. This foundation has shaped her work in ensuring women’s health messaging is evidence‑based, accessible, and designed to drive real‑world outcomes.
At Hologic, Aggie has been instrumental in elevating attention to under‑recognised and under‑treated women’s health issues, including preventive screening, sexual and reproductive health, and heavy menstrual bleeding. Her leadership has helped normalise conversations often avoided due to stigma, empowering women to seek information, diagnosis, and care earlier.
Aggie is particularly recognised for reframing marketing as a public health lever, not just a commercial function. Her work connects education, awareness, digital innovation, and clinical credibility to improve health literacy and engagement—especially among women who may delay care due to embarrassment, lack of access, or misinformation.
Aggie regularly contributes to national leadership forums, industry conferences, and community events, including International Women’s Day panels and major marketing and customer experience conferences. Her speaking focuses on the intersection of women’s health, leadership, workplace wellbeing, and purpose‑led growth, as well as resilience and non‑linear career pathways for women in leadership.
Aggie holds a Master of Marketing from Melbourne Business School and is widely respected for bridging commercial performance with social impact. She is passionate about making women’s health visible, discussable, and actionable—in healthcare systems, workplaces, and society at large.
Source: Supplied
Media access credit: Medical Technology Association of Australia (MTAA)
You Might also like
-
Integrated oral health care in midwifery practice
There is limited emphasis being placed on perinatal oral health by prenatal care providers in Australia. Pregnant women have no system in place that can offer them regular oral assessment during pregnancy and prompt dental treatment at minimal or no cost as experienced in other countries. To address the oral health needs of pregnant women, a unique midwifery initiated oral health (MIOH) model was developed to promote and maintain maternal oral health.
-
Landmark Australian-led study revises thresholds to diagnose and treat anaemia
In 2014, WEHI researchers began a study at the request of the World Health Organization (WHO), to formally review its global anaemia guidelines that were last updated in 1968.
Study lead and Acting WEHI Deputy Director, Professor Sant-Rayn Pasricha, speaking to Australian Health Journal said while anaemia can be diagnosed by measuring the amount of haemoglobin in the blood, there is currently no consensus on the thresholds that should be used to define the condition. -
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.